Sale of In-Vitro Fertilization Media, Reagents and related Consumables used in Assisted Reproductive Technology Procedures
The Apex Drug and Medical Device Regulator has strictly restricted the supply of critical Laboratory Consumables used in In-Vitro Fertilization (IVF) and Assisted Reproductive Technology (ART) exclusively to Registered Fertility Centers.
The Core Mandate
According to the circular (File No. MED/71/2026-eoffice, dated 23 June 2026), all media, reagents, and related consumables utilized in ART procedures—such as IVF and cryopreservation—are legally classified as medical devices. Consequently, they fall under the strict jurisdiction of the Medical Devices Rules, 2017, meaning any manufacturer or importer must possess a valid license to handle these products
The Problem Addressed
The Drugs Controller General of India (DCGI), Dr. Rajeev Singh Raghuvanshi, noted that the department received concerning reports of IVF media and consumables being supplied to Unregistered Medical Facilities.
The Risks: Operating through Unregistered Clinics poses serious threats to patient health and welfare. Unregulated environments can expose couples to infection risks, substandard laboratory protocols, and the potential misuse of sensitive reproductive technologies
The New Restriction
To enforce Safe and Ethical Reproductive Healthcare Practices, the CDSCO has ordered all stakeholders (manufacturers, importers, and suppliers) to strictly verify and ensure that these consumables are only distributed to centers registered under:
The Surrogacy (Regulation) Act, 2021
The Assisted Reproductive Technology (Regulation) Act, 2021
Impact
This directive marks a massive regulatory crackdown aimed at bringing transparency to India’s booming fertility market.
Medical experts have widely welcomed the move. Top gynecologists and IVF specialists note that because the quality and traceability of laboratory media directly impact embryonic development and treatment outcomes, cutting off supplies to unverified, non-compliant clinics is a necessary step to safeguard patient safety and build public trust.
đź”— Official References & Links
- Official CDSCO Notification Link: You can access and download the exact circular referenced via the Official CDSCO Circular PDF.
- CDSCO Latest Circulars Repository: To track this and concurrent regulatory updates, visit the CDSCO Latest Circulars Portal.
- Media Reference: For the complete media narrative surrounding the implementation, consult the Times of India Article
